ArticleJournal of anesthesia2026
Intraoperative lactate as an early risk marker in laparoscopic liver resection and its association with modifiable hemodynamic parameters: a retrospective cohort study.
Article in Journal of anesthesia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Midazolam premedication: shaping pediatric perioperative outcomes.Journal of anesthesia · 2026Article
- Reply to the Comments on "Intraoperative Lactate as an Early Risk Marker in Laparoscopic Liver Resection and Its Association with Modifiable Hemodynamic Parameters: A Retrospective Cohort Study".Journal of anesthesia · 2026Article
- Comments on "Intraoperative lactate as an early risk marker in laparoscopic liver resection and its association with modifiable hemodynamic parameters: a retrospective cohort study" by Nakanishi et al.Journal of anesthesia · 2026Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
Abstract
purposeEarly postoperative lactate ≥ 3 mmol/L is associated with adverse outcomes following open hepatectomy; however, the prognostic utility of intraoperative lactate in laparoscopic liver resection (LLR) and its associations with hemodynamic parameters remain unclear.
methodsThis retrospective cohort study included adults undergoing LLR at a university hospital between January 2017 and August 2024. The predictor was peak arterial lactate from skin incision to PACU discharge, dichotomized at 3 mmol/L. The primary outcome was a 30-day composite of all-cause mortality, post-hepatectomy liver failure (PHLF), or acute kidney injury (AKI). As a secondary objective, associations between intraoperative lactate ≥ 3 mmol/L and prespecified hemodynamic exposures (net fluid balance, vasopressor dose, and indices of low mean arterial pressure (MAP), low or high stroke volume variation (SVV), and low cardiac index) were explored using multivariable logistic regression models.
resultsAmong 257 patients, 143 (55.6%) had lactate ≥ 3 mmol/L. The composite outcome was more frequent in patients with lactate ≥ 3 mmol/L than in those with lactate < 3 mmol/L (15.4% vs. 4.4%; risk difference, 11.0%; 95% confidence interval, 3.6-18.3%), and discrimination was modest (AUC 0.695). AKI accounted for most events (12.6% vs. 0.9%; risk difference, 11.7%; 95% confidence interval, 5.8-18.2%); mortality and PHLF were similar. Lower net fluid balance and greater exposure to low MAP and low SVV were associated with lactate elevation, whereas vasopressor dose, high SVV, and low cardiac index were not.
conclusionIn LLR, intraoperative lactate ≥ 3 mmol/L showed modest discrimination for the 30-day composite outcome, driven primarily by AKI.
Indexed as
Identifiers
42091706What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.